Psoriasis mutations disrupt CARD14 autoinhibition promoting BCL10-MALT1-dependent NF-κB activation.

Inherited and de novo mutations in the CARD14 gene promote the development of psoriasis, an inflammatory disease of the skin. Caspase recruitment domain-containing protein 14 (CARD14) is a member of the CARMA protein family that includes the structurally related CARD11 adaptor that mediates NF-κB activation by antigen receptors. We investigated ...
the mechanism by which CARD14 mutation in psoriasis activates NF-κB. In contrast with wild-type CARD14, CARD14(E138A) and CARD14(G117S) psoriasis mutants interacted constitutively with BCL10 and MALT1, and triggered BCL10- and MALT1-dependent activation of NF-κB in keratinocytes. These alterations disrupted the inhibitory effect of the CARD14 linker region (LR) on NF-κB activation by facilitating BCL10 binding. Therefore, psoriasis mutations activated CARD14 by a mechanism analogous to oncogenic CARD11 mutations in non-Hodgkin B cell lymphomas. CARD14(E138A) also stimulated MALT1 paracaspase activity and activated both ERK1/2 and p38α MAP kinases. Inhibition of MALT1 with mepazine reduced CARD14(E138A)-induced expression of specific psoriasis-associated transcripts in keratinocytes. Our results establish the mechanism whereby gain-of-function CARD14 variants, which induce psoriatic disease in affected individuals, activate pro-inflammatory signalling.
Mesh Terms:
Adaptor Proteins, Signal Transducing, B-Cell CLL-Lymphoma 10 Protein, CARD Signaling Adaptor Proteins, Caspases, Cell Line, Guanylate Cyclase, Humans, Immunoprecipitation, Keratinocytes, MAP Kinase Signaling System, Membrane Proteins, Mitogen-Activated Protein Kinase 14, Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 Protein, Mutation, NF-kappa B, Neoplasm Proteins, Protein Binding, Psoriasis, RNA, Small Interfering, Signal Transduction
Biochem. J.
Date: Dec. 15, 2015
Download Curated Data For This Publication
208217
Switch View:
  • Interactions 3